This HTML5 document contains 71 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dcthttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n16https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n17http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Vi_capsular_polysaccharide_vaccine
rdf:type
yago:Substance100020090 dbo:ChemicalSubstance owl:Thing yago:Matter100020827 yago:Immunogen103562739 dbo:Vaccine yago:Vaccine104517535 wikidata:Q8386 yago:Antigen115037339 yago:PhysicalEntity100001930 yago:WikicatVaccines dbo:Drug n17:ChemicalObject
rdfs:label
Vi capsular polysaccharide vaccine
rdfs:comment
The Vi capsular polysaccharide vaccine (or ViCPS) is a typhoid vaccine recommended by the World Health Organization for the prevention of typhoid (another is Ty21a). The vaccine was first licensed in the US in 1994 and is made from the purified Vi capsular polysaccharide from the Ty2 Salmonella Typhi strain; it is a subunit vaccine.
dct:subject
dbc:Subunit_vaccines dbc:Typhoid_fever
dbo:wikiPageID
15820568
dbo:wikiPageRevisionID
1095533542
dbo:wikiPageWikiLink
dbr:Pseudomonas_aeruginosa dbr:Recombinant_DNA dbr:Ty21a dbr:Sanofi_Pasteur dbr:Typhoid dbr:Conjugate_vaccine dbr:Paratyphoid_fever dbr:Exotoxin_A dbr:Subunit_vaccine dbc:Subunit_vaccines dbr:Salmonella_enterica_subsp._enterica dbr:Typhoid_vaccine dbc:Typhoid_fever dbr:Bacterial_capsule dbr:Tetanus_toxoid dbr:Typhoid_conjugate_vaccine dbr:Typhim_VI dbr:Typherix dbr:World_Health_Organization dbr:GlaxoSmithKline dbr:Centers_for_Disease_Control_and_Prevention
owl:sameAs
freebase:m.03x_s8t yago-res:Vi_capsular_polysaccharide_vaccine wikidata:Q7924335 n16:4xrQw
dbp:vaccineType
polysaccharide
dbp:wikiPageUsesTemplate
dbt:Drugbankcite dbt:Vaccine-stub dbt:Vaccines dbt:Cascite dbt:Clarify dbt:Reflist dbt:Chemspidercite dbt:Drugbox dbt:Drugs.com
dbp:atcSuffix
AP03
dbp:atcPrefix
J07
dbp:casNumber
1704529
dbp:chemspiderid
none
dbp:legalUs
Rx-only
dbp:routesOfAdministration
intramuscular injection, subcutaneous injection
dbp:target
dbr:Typhoid
dbp:tradename
Typherix, Typhim VI
dbp:type
vaccine
dbp:verifiedfields
changed
dbp:verifiedrevid
377100707
dbo:abstract
The Vi capsular polysaccharide vaccine (or ViCPS) is a typhoid vaccine recommended by the World Health Organization for the prevention of typhoid (another is Ty21a). The vaccine was first licensed in the US in 1994 and is made from the purified Vi capsular polysaccharide from the Ty2 Salmonella Typhi strain; it is a subunit vaccine.
prov:wasDerivedFrom
wikipedia-en:Vi_capsular_polysaccharide_vaccine?oldid=1095533542&ns=0
dbo:wikiPageLength
4852
dbo:alternativeName
Typherix, Typhim VI
dbo:casNumber
1704529-13-4
foaf:isPrimaryTopicOf
wikipedia-en:Vi_capsular_polysaccharide_vaccine